<DOC>
	<DOCNO>NCT00956189</DOCNO>
	<brief_summary>The investigator develop easy identification model identify metabolic syndrome patient schizophrenia schizoaffective disorder receive treatment clozapine , olanzapine , risperidone . The accuracy investigator ' model show well . In study , investigator aim ( 1 ) examine whether developed identification model generalize patient take antipsychotic patient diagnosis ; ( 2 ) develop easy risk score validate ; ( 3 ) switch antipsychotic amisulpride aripiprazole metabolic syndrome , compare change metabolic parameter include adiponectin , analyze association genetic variant , demography , clinical variable ; ( 4 ) establish model use artificial neural network statistic method predict metabolic response switch amisulpride aripiprazole ; ( 5 ) investigate effect antipsychotic adiponectin gene expression secretion differentiation process 3T3L1 adipocytes .</brief_summary>
	<brief_title>Identification Treatment Response Prediction Antipsychotic-Related Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Stage I identification metabolic syndrome : A diagnosis schizophrenia , schizoaffective disorder , delusional disorder , mood disorder , anxiety disorder base DSMIVTR criterion . Age least 20 year old . The current antipsychotic drug use least 3 month evaluation . Psychiatrically stable Clinical Global Impression Severity scale ( CGIS ) great 5 Severe uncontrolled medical illness , include cardiovascular , hepatic , renal metabolic disease ( eg . cancer , poorcontrol hypertension , diabetes mellitus , metabolic disease ) . Organic mental neurological disorder , substance abuse dependence ( alcohol , amphetamine , heroin ) . Pregnant breastfeed woman . Patients Yuli Veterans Hospital , attend previous study identification model . Stage II switch response : The Stage I criteria . Fulfill metabolic syndrome criterion . The Stage I criteria except 4th item . Treated depot form antipsychotic .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Antipsychotic Agents</keyword>
	<keyword>Metabolic Syndrome X</keyword>
	<keyword>Identification</keyword>
	<keyword>Prediction</keyword>
</DOC>